HACKENSACK UMC AT PASCACK VALLEY — History
CCN 310130 | 3-year financial timeline | COVID resilience: 68/100
🛡️ Public data only — no PHI permitted on this instance.
$149M
Latest Revenue (FY2022)
+5.8%
Revenue CAGR (3yr)
15.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $133M | $139M | $149M | +6.9% | +5.8% |
| Operating Expenses | $121M | $118M | $127M | +7.4% | +2.2% |
| Operating Margin | 8.9% | 15.4% | 15.0% | -2.8% | +29.5% |
| Net Income | $12M | $21M | $22M | +3.9% | +37.0% |
| Licensed Beds | 78 | 78 | 78 | +0.0% | +0.0% |
| Total Patient Days | 16,902 | 15,694 | 15,825 | +0.8% | -3.2% |
| Medicare Day % | 32% | 34% | 32% | -6.0% | +0.5% |
| Medicaid Day % | 1% | 1% | 1% | -43.8% | -29.0% |
COVID Impact & Recovery
Resilience Score: 68/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +11.9% ($133M → $149M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.8%
This Hospital
+7.6%
State Avg
Latest Margin
15.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $157M | 18.0% |
| FY2024 (proj) | $165M | 21.0% |
| FY2025 (proj) | $173M | 24.0% |